Aeschbacher, Nathan D. https://orcid.org/0009-0006-8344-314X
Maurer, Alexander
Beintner-Skawran, Stephan
Messerli, Michael
Sah, Bert-Ram
Kaufmann, Philipp A.
Holzmann, David
Meerwein, Christian
Bankel, Lorenz
Rordorf, Tamara
Andratschke, Nicolaus
Balermpas, Panagiotis
Guckenberger, Matthias
Mangana, Joanna
Mihic-Probst, Daniela
Rupp, Niels
Huellner, Martin W.
Article History
Received: 10 December 2025
Accepted: 1 February 2026
First Online: 12 February 2026
Declarations
:
: No potential conflicts of interest directly related to the current work were disclosed. A.M. received speaker honoraria from Jansen Pharmaceutica N.V unrelated to the current work. S.B. reports an advisory role for Novartis, Switzerland, unrelated to the current work. J.M. has intermittent project focused consultant/advisory relationships or has received speaker fees from Merck Sharp & Dohme, Novartis, Janssen, Bristol Myers Squibb and Pierre Fabre and has received travel support from Sunpharma, L’Oréal, Merck Sharp & Dohme, Bristol Myers and Squibb und Pierre Fabre outside of the submitted work. M.H. received grants and speaker honoraria from GE HealthCare, a fund by the Alfred and Annemarie von Sick legacy and a grant from the clinical research priority program (CRPP) Artificial Intelligence in Oncological Imaging Network of the University of Zurich. All other authors declare no conflicts of interest.